FLS
61
13
AME
72
6
OXY
40
2
LRCX
62
6
T
23
2
PH
62
2
NOC
54
6
PNR
51
3
CAT
58
-8
LNC
75
2
EFX
54
2
BIIB
50
4
PFE
33
-8
MMM
56
2
PCAR
52
-10
AES
47
-3
SNA
52
2
EW
58
5
WAT
49
2
PVH
32
2
FLS
61
13
AME
72
6
OXY
40
2
LRCX
62
6
T
23
2
PH
62
2
NOC
54
6
PNR
51
3
CAT
58
-8
LNC
75
2
EFX
54
2
BIIB
50
4
PFE
33
-8
MMM
56
2
PCAR
52
-10
AES
47
-3
SNA
52
2
EW
58
5
WAT
49
2
PVH
32
2
Financhill
Back

SPDR Portfolio Developed World ex-US ETF Vs. Novo Nordisk A/S Industry Stock Comparison

Buy
52

SPDW
SPDR Portfolio Developed World ex-US ETF

Last Price:
$44.79
Seasonality Move:
-0.85%
Sell
24

NVO
Novo Nordisk A/S

Last Price:
$48.11
Seasonality Move:
4.04%
Buy
52
SPDR Portfolio Developed World ex-US ETF (SPDW) is a Buy

Is SPDR Portfolio Developed World ex-US ETF a Buy, Sell or Hold?

  • The current SPDR Portfolio Developed World ex-US ETF [SPDW] share price is $44.78. The Score for SPDW is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SPDW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $48.09. The Score for NVO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPDW Stock Price Chart

What is SPDR Portfolio Developed World ex-US ETF's stock price today?

  • The SPDR Portfolio Developed World ex-US ETF share price today is $44.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPDW is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $48.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

SPDW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.38 Buy
Relative Strength Index (14 RSI): 61.18 Buy
Chaikin Money Flow: -1916493 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.04 - 44.58) Buy
Bollinger Bands (100): (41.69 - 43.97) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 46.95 Sell
Chaikin Money Flow: -7995446 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.92 - 49.34) Sell
Bollinger Bands (100): (48.13 - 56.93) Sell

SPDW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.59 Buy
20-day SMA: 44.04 Buy
50-day SMA: 43.63 Buy
200-day SMA: 40.7 Buy
8-day EMA: 23.59 Buy
20-day EMA: 11.55 Buy
50-day EMA: 5.03 Buy
200-day EMA: 1.32 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.04 Sell
20-day SMA: 48.12 Sell
50-day SMA: 50 Sell
200-day SMA: 60.88 Sell
8-day EMA: 48.42 Sell
20-day EMA: 48.52 Sell
50-day EMA: 50.22 Sell
200-day EMA: 63.1 Sell

SPDR Portfolio Developed World ex-US ETF Earnings Growth & SPDW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.16 per share.

SPDR Portfolio Developed World ex-US ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):